Free Trial
NASDAQ:SRTS

Sensus Healthcare Q2 2025 Earnings Report

Sensus Healthcare logo
$4.34 -0.10 (-2.25%)
Closing price 04:00 PM Eastern
Extended Trading
$4.33 -0.01 (-0.23%)
As of 04:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sensus Healthcare EPS Results

Actual EPS
N/A
Consensus EPS
$0.01
Beat/Miss
N/A
One Year Ago EPS
N/A

Sensus Healthcare Revenue Results

Actual Revenue
N/A
Expected Revenue
$9.30 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Sensus Healthcare Announcement Details

Quarter
Q2 2025
Time
Before Market Opens
Conference Call Date
Thursday, August 7, 2025
Conference Call Time
4:30PM ET

Conference Call Resources

Sensus Healthcare Earnings Headlines

This Could Be the Most Profitable Season of Your Life
Institutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the same point in every cycle when crypto enters its most explosive phase — and two experts are showing how to ride it. Inside The Crypto Code Workshop, you’ll get their step-by-step system and $10 in free Bitcoin for attending.
See More Sensus Healthcare Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Sensus Healthcare? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sensus Healthcare and other key companies, straight to your email.

About Sensus Healthcare

Sensus Healthcare (NASDAQ:SRTS) is a medical technology company specializing in the design, development and commercialization of superficial radiotherapy systems for the treatment of non-melanoma skin cancers and keloids. Its flagship products, the SRT-100 and SRT-100+ systems, deliver low-energy X-ray therapy in a non-invasive, outpatient setting, providing clinicians with an alternative to surgery and enabling patients to preserve cosmetic appearance and minimize recovery time.

The company’s product portfolio includes the SRT-100 series systems, handpieces and applicators tailored to various lesion sizes and anatomical locations. These systems employ targeted superficial radiation to deliver precise doses to the treatment site while sparing surrounding healthy tissue. Sensus Healthcare also offers comprehensive service, training and maintenance programs designed to support clinic staff and ensure consistent, high-quality patient care.

Founded in the late 1990s and headquartered in Orlando, Florida, Sensus Healthcare has expanded its presence across the United States and into select international markets. The company’s direct sales organization serves dermatology, oncology and plastic surgery practices, while strategic partnerships and distribution agreements facilitate access in Europe, Latin America and the Middle East. Ongoing research and development efforts focus on enhancing device functionality, streamlining clinical workflows and exploring new therapeutic applications.

Under the leadership of Chief Executive Officer José Báez, the company prioritizes regulatory compliance, quality assurance and evidence-based clinical data. Sensus Healthcare’s executive team and board of directors bring extensive experience in medical device innovation, commercial strategy and healthcare operations. Through collaboration with key opinion leaders and professional societies, the company continues to advance the adoption of superficial radiotherapy as a standard of care in dermatologic oncology.

View Sensus Healthcare Profile

More Earnings Resources from MarketBeat